Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
A validated regulatory network for Th17 cell specification.
New drug for relapsing multiple sclerosis.
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
PET imaging in multiple sclerosis.
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
How much sunlight is enough?
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
Navigating the "liberation procedure": a qualitative study of motivating and hesitating factors among people with multiple sclerosis.
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Intractable hiccup caused by spinal cord lesions in demyelination disease.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Vitamin d assays: past and present debates, difficulties, and developments.
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
Supporting work for people with multiple sclerosis.
Improving the quality of mental health care in Multiple Sclerosis.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.

Pages